XGN
USDExagen Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$11.080
उच्च
$11.500
कम
$10.500
मात्रा
1.42M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
237.0M
उद्योग
Diagnostics & Research
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
0.23M
एक्सचेंज
NGM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
BTIG Maintains Buy on Exagen, Raises Price Target to $15
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $13 to $15.
Exagen Inc. Reports Strong Q3 2025 Results
CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent
Canaccord Genuity Maintains Buy on Exagen, Raises Price Target to $15
Canaccord Genuity analyst Kyle Mikson maintains Exagen with a Buy and raises the price target from $11 to $15.
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology's
BTIG Maintains Buy on Exagen, Raises Price Target to $13
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $11 to $13.
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।